Black Rock Inc. Phathom Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,926,373 shares of PHAT stock, worth $28.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,926,373

Previous 2,745,380 6.59%

Holding current value

$28.5 Million

Previous $29.2 Million 3.38%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$8.97 - $12.05 $1.62 Million - $2.18 Million	180,993 Added 6.59%	2,926,373 $30.1 Million
Q1 2024 May 10, 2024	BUY	$6.21 - $11.05 $412,896 - $734,703	66,489 Added 2.48%	2,745,380 $29.2 Million
Q4 2023 Feb 13, 2024	BUY	$6.99 - $10.71 $1.69 Million - $2.58 Million	241,149 Added 9.89%	2,678,891 $24.5 Million
Q3 2023 Nov 13, 2023	BUY	$10.26 - $15.7 $4.46 Million - $6.83 Million	435,110 Added 21.73%	2,437,742 $25.3 Million
Q2 2023 Aug 11, 2023	BUY	$7.28 - $14.32 $2.69 Million - $5.29 Million	369,722 Added 22.64%	2,002,632 $28.7 Million
Q1 2023 May 12, 2023	SELL	$6.19 - $12.36 $380,814 - $760,399	-61,521 Reduced 3.63%	1,632,910 $11.7 Million
Q4 2022 Feb 13, 2023	BUY	$9.18 - $11.53 $1.39 Million - $1.74 Million	151,281 Added 9.8%	1,694,431 $19 Million
Q3 2022 Nov 14, 2022	SELL	$6.46 - $12.11 $223,432 - $418,848	-34,587 Reduced 2.19%	1,543,150 $17.1 Million
Q2 2022 Aug 12, 2022	BUY	$6.2 - $15.5 $1.24 Million - $3.09 Million	199,220 Added 14.45%	1,577,737 $13.3 Million
Q1 2022 May 12, 2022	SELL	$11.55 - $20.06 $1.09 Million - $1.9 Million	-94,608 Reduced 6.42%	1,378,517 $18.8 Million
Q4 2021 Feb 10, 2022	BUY	$17.83 - $33.15 $5.18 Million - $9.62 Million	290,247 Added 24.54%	1,473,125 $29 Million
Q3 2021 Nov 09, 2021	BUY	$30.69 - $36.83 $688,714 - $826,502	22,441 Added 1.93%	1,182,878 $38 Million
Q2 2021 Aug 11, 2021	BUY	$32.66 - $39.87 $37.9 Million - $46.3 Million	1,160,437 New	1,160,437 $39.3 Million

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.2M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $382M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account